Celebrating the International Day of Older Persons

October 1 is the United Nations International Day of Older Persons, created by a UN General Assembly resolution in 1990 and first observed in 1991 to focus global attention on aging and the rights and needs of older people. The 2025 theme is “Older Persons Driving Local and Global Action: Our time is now,” a reminder that older adults are not a monolith of vulnerability but a massive source of capability and leadership.

The demographic tide that keeps rising

The world is growing older fast. By 2050, roughly 16% of the global population will be 65 or older, a share larger than the child population in many countries. Demography is not destiny, but it is policy pressure. It touches pensions, health systems, labor markets, housing, and climate adaptation.

The UN’s Decade of Healthy Ageing (2021–2030) reframes the goal from “adding years to life” to “adding life to years,” with four pillars that show up throughout this piece: age-friendly environments, combating ageism, integrated care, and access to long-term care.

The science of aging in one page

Aging biology is not a single switch. It is a network of cellular and molecular changes that accumulate over time and degrade resilience. Research programs often target energy sensing, protein quality control, cellular senescence, immune aging, and the epigenome. The practical question is simple. Which levers have human data that matter for older adults today?

Below, “what works now” pulls from randomized trials and clinical evidence. “What looks promising” highlights early, carefully contextualized findings.

What works now: evidence you can take to clinic and community

Vaccines, immune tuning, and the respiratory gauntlet

Older adults face high risk from influenza, COVID-19, and RSV. New RSV vaccines are now authorized for adults 60 and older, and safety monitoring for this age group is active at CDC. That is immediate risk reduction. At the same time, small placebo-controlled trials suggest that dialing down mTOR, a nutrient-sensing pathway, can improve vaccine responses in older adults. In one study, low-dose everolimus increased influenza vaccine antibody responses by about 20% and reduced markers of T-cell exhaustion. This is not a license to self-experiment. It is a human proof that an aging pathway is tunable.

Hearing health to protect brain health

The ACHIEVE randomized trial tested whether treating hearing loss slows cognitive decline. Across all participants the effect was neutral at three years, but among the higher-risk subgroup the hearing intervention cut cognitive decline by nearly half. Translation for public health: treat hearing loss early in those with elevated dementia risk.

Calories, clocks, and the pace of aging

In the CALERIE randomized trial, two years of moderate caloric restriction produced a modest but statistically significant slowing of biological aging measured by the DNA-methylation “pace of aging” algorithm, without changing several epigenetic age clocks. This does not mean everyone should restrict calories. It does show that a geroscience lever is detectable in humans with a modern biomarker.

Muscle, protein, and the physics of independence

Sarcopenia silently drives falls, frailty, and loss of autonomy. Progressive resistance training remains the most reliable intervention to build strength well into the eighth and ninth decades, and clinical guidelines advise higher protein targets for older adults than for younger adults. ESPEN recommends at least 1.0 g of protein per kilogram per day, often higher when ill or in rehab, paired with adequate energy and fluids. That combination preserves lean mass and supports function.

Cardiometabolic risk is still the kingmaker

For adults with established cardiovascular disease and overweight or obesity, the SELECT trial found that semaglutide reduced major adverse cardiovascular events by about 20% versus placebo. Cardiometabolic risk control is not just lifespan insurance. It is quality-of-life insurance for older adults who want stamina for work, caregiving, and play.

What looks promising: early human data worth watching

Clearing senescent cells

Cellular senescence protects against cancer but accumulates with age, secreting inflammatory factors that damage tissue. In a 2019 pilot, a short course of dasatinib plus quercetin decreased senescent cell markers in human fat and skin and lowered circulating SASP proteins. More recently, a small single-arm study in older adults suggested improved mobility and cognition after brief senolytic treatment. These studies are not definitive and raise safety and dosing questions. They do validate a core hypothesis in people and justify larger randomized trials.

Integrated care for intrinsic capacity

WHO’s ICOPE approach targets mobility, cognition, mood, vision, and hearing as a package, delivered in primary care with community support. The point is not more specialist silos but a unified plan that maintains what WHO calls “intrinsic capacity.” Trials and pilot programs continue to evaluate outcomes and scalability country by country.

The social determinants you can feel

Ageism is a public health problem

Ageism is common, correlated with worse physical and mental health, and costs economies billions each year through lost work, under-treatment, and social exclusion. Reducing ageism is not a courtesy. It is a health intervention embedded in law, workplace practice, clinical protocols, and media narratives.

The longevity economy is already here

People 50 and older contribute trillions to economic output and taxes, and they drive a large share of consumer spending. That reality should reshape product design, financial services, urban planning, and hiring practices. Bias that sidelines older workers leaves growth on the table.

Heat, housing, and the new risk map

Age blunts thermoregulation. Chronic disease and medications can amplify that risk. Absent adaptation, exposure of older adults to dangerous heat waves is projected to at least double by mid-century. Healthy longevity now requires climate-aware housing, community cooling plans, hydration protocols in long-term care, and targeted emergency response.

A practical lens: ten high-yield actions for systems and citizens

1. Vaccinate on time for influenza, COVID-19, and now RSV where indicated. Treat vaccination as foundational risk control rather than optional extra.
2. Screen and treat hearing loss, especially in people at elevated dementia risk. The cognitive dividend is plausible and the social dividend is immediate.
3. Program resistance training twice weekly as a default in primary care plans for older adults. Pair with adequate protein and hydration.
4. Manage cardiometabolic risk aggressively. For secondary prevention populations that fit SELECT-like profiles, pharmacotherapy can deliver event reduction on top of lifestyle.
5. Adopt ICOPE-style integrated assessments that combine mobility, cognition, mood, vision, and hearing into one plan.
6. Design care around intrinsic capacity, not just disease lists. That includes nutrition services, dental care, deprescribing, and sleep.
7. Tackle ageism in hiring, clinical decision-making, and media. Healthy longevity needs social scaffolding.
8. Make homes and neighborhoods heat-smart with shade, ventilation, and neighbor check-ins during heat alerts.
9. Use validated biomarkers with caution. Epigenetic clocks can reflect intervention effects, but choose outcomes that matter for function and survival.
10. Support rigorous geroscience trials. Early senolytic data are intriguing. The field now owes older adults well-powered randomized studies with clinical endpoints and safety follow-up.

The narrative we should tell on this day

We can celebrate longer lives without romanticizing fragility or ignoring inequity. The best evidence says that healthy longevity is built from three strands woven together. First, prevention and risk control that modern cardiometabolic and infectious disease science already delivers. Second, functional capacity defended by muscle, hearing, vision, and cognition through integrated, person-centered care. Third, biological levers that are beginning to move in humans, from caloric restriction signals to targeted immune tuning and cellular senescence programs. Add policy that fights ageism and builds age-friendly cities, and the International Day of Older Persons stops being an annual reminder. It becomes a scoreboard for progress.

References

1. American College of Sports Medicine. (n.d.). Physical activity guidelines. https://acsm.org/education-resources/trending-topics-resources/physical-activity-guidelines/
2. Britton, A., Link-Green, A., Hall, E., et al. (2024). Use of respiratory syncytial virus (RSV) vaccines for adults: Updated recommendations of the Advisory Committee on Immunization Practices—United States, 2024. MMWR Morbidity and Mortality Weekly Report, 73(32), mm7332e1. https://doi.org/10.15585/mmwr.mm7332e1
3. Centers for Disease Control and Prevention. (2025, July 8). Vaccines for adults | RSV. https://www.cdc.gov/rsv/vaccines/adults.html
4. Hearing intervention trial (ACHIEVE) – news summary. (2023, July 18). National Institute on Aging. Hearing aids slow cognitive decline in people at high risk. https://www.nia.nih.gov/news/hearing-aids-slow-cognitive-decline-people-high-risk
5. Justice, J. N., Nambiar, A. M., Tchkonia, T., et al. (2019). Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label pilot study. EBioMedicine, 40, 554–563. https://doi.org/10.1016/j.ebiom.2018.12.052
6. Lincoff, A. M., Botros, F. T., Wang, T., et al. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2307563
7. Mannick, J. B., Del Giudice, G., Lattanzi, M., et al. (2014). mTOR inhibition improves immune function in the elderly. Science Translational Medicine, 6(268), 268ra179. https://pubmed.ncbi.nlm.nih.gov/25540326/
8. Mannick, J. B., Morris, M., Hockey, H.-U. P., et al. (2018). TORC1 inhibition enhances immune function and reduces infections in the elderly. Science Translational Medicine, 10(449), eaaq1564. https://doi.org/10.1126/scitranslmed.aaq1564
9. Nambiar, A. M., Kellogg, D. L., Justice, J. N., et al. (2023). Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: Results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. EBioMedicine, 90, 104481. https://doi.org/10.1016/j.ebiom.2023.104481
10. United Nations. (n.d.). International Day of Older Persons. https://www.un.org/en/observances/older-persons-day
11. United Nations, Department of Economic and Social Affairs, Programme on Ageing. (n.d.). International Day of Older Persons—Homepage (UNIDOP). https://social.desa.un.org/issues/ageing/international-day-of-older-persons-homepag
12. United Nations, Department of Economic and Social Affairs, Population Division. (2022). World population prospects 2022: Summary of results. https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf
13. Volkert, D., Beck, A. M., Cederholm, T., et al. (2019). ESPEN guideline on clinical nutrition and hydration in geriatrics. Clinical Nutrition, 38(1), 10–47. https://www.espen.org/files/ESPEN-Guidelines/ESPEN_guideline_on_clincal_nutrition_and_hydration_in_geriatrics.pdf
14. Volkert, D., Beck, A. M., Cederholm, T., et al. (2022). ESPEN practical guideline: Clinical nutrition and hydration in geriatrics. Clinical Nutrition, 41, 958–989. https://www.espen.org/files/ESPEN-Guidelines/ESPEN_practical_guideline_Clinical_nutrition_and_hydration_in_geriatrics.pdf
15. World Health Organization. (2021). Global report on ageism. World Health Organization. https://www.who.int/publications/i/item/9789240016866
16. World Health Organization. (2024). Integrated care for older people (ICOPE): Guidance for person-centred assessment and pathways in primary care (2nd ed.). World Health Organization. https://iris.who.int/handle/10665/376612
17. World Health Organization. (n.d.). WHO’s work on the UN Decade of Healthy Ageing (2021–2030). https://www.who.int/initiatives/decade-of-healthy-ageing
18. AARP. (2020). The Longevity Economy® Outlook. AARP Public Policy Institute. https://www.aarp.org/pri/topics/work-finances-retirement/economics-aging/longevity-economy-outlook/